Search
Search Results
##search.searchResults.foundPlural##
-
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1915PDF: 1458HTML: 694 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1471PDF: 1173HTML: 282 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2377PDF: 953HTML: 391 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2665HTML: 366PDF: 997 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2388PDF: 1748HTML: 753 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1957PDF: 982HTML: 1580 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3470PDF: 1818HTML: 1197 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2745PDF: 1276HTML: 180 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1795PDF: 834HTML: 1526 -
Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma
1620PDF: 807HTML: 4609Figure 1: Chest radiograph: 292Figure 2: Flow cytometer analysis of pleural fluid: 250 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2681PDF: 892HTML: 1768 -
QUALITY OF LIFE ASSESSMENT IN MULTIPLE MYELOMA PATIENTS UNDERGOING DOSE-REDUCED TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION
1530PDF: 781HTML: 1409cover letter: 270 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
315PDF: 809HTML: 82 -
Brain abscesses caused by Nocardia paucivorans in a multiple myeloma patient treated with lenalidomide and dexamethasone: a case report and review of literature.
1842PDF: 1166HTML: 6578original file with images: 348 -
Bilateral Pleural Effusions due to Pulmonary Amyloidosis as the Presenting Manifestation of Multiple Myeloma
1749PDF: 855HTML: 4435Figure 1: 210Untitled: 204Untitled: 264 -
LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE
1504PDF: 998HTML: 1312fig 1A: 253figure1B: 214 -
SOLITARY PLASMACYTOMA
4435PDF: 2314HTML: 1452fIGURES 1,2: 294 -
An unusual cause of anemia and encephalopathy
4277PDF: 954HTML: 1563 -
Multiple myeloma diagnosed by CT-guided rib biopsy after a hemodilute bone marrow aspirate, in a patient with a biclonal pattern on serum protein electrophoresis Multiple Myeloma diagnosed with CT-guided rib biopsy
309PDF: 169HTML: 286 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2656PDF: 996HTML: 2590 -
-
FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS Outcomes of ASCT in NDMM elderly fit patients
1168PDF: 694Html: 189 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2532PDF: 1962HTML: 1097







